In Vitro Hematological and in Vivo Vasoactivity Assessment of Dextran Functionalized Graphene

Scientific Reports - United Kingdom
doi 10.1038/srep02584
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Anti-Her2 Functionalized Graphene Oxide as Survivin-siRNA Delivery Carrier Inhibits Breast Carcinoma Growth in Vitro and in Vivo

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Preclinical and Clinical in Vitro in Vivo Correlation of an hGH Dextran Microsphere Formulation

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2007English

In Vitro and in Vivo Toxicity Assessment of Nanoparticles

International Nano Letters
MedicineBioengineeringBiomedical EngineeringPharmaceutical Science
2017English

In Vitro and in Vivo Assessment of Genotoxic Activity of Petiveria Alliacea

African Journal of Pharmacy and Pharmacology
2016English

In-Vivo Assessment of In-Vitro Killing Patterns of Pseudomonas Aeruginosa

Journal of Antimicrobial Chemotherapy
Infectious DiseasesMicrobiologyPharmacology
1985English

Effect of Di-Ethyl Aminoethyl (DEAE) Dextran on the Infectivity Titre of Sheep Pox Virus In-Vitro and In-Vivo

Journal of Veterinary Medical Research
2010English

In Vitro and in Vivo Assessment of Docetaxel Formulation Developed for Esophageal Stents

AAPS PharmSciTech
EvolutionEcologySystematicsCrop ScienceAquatic ScienceBehaviorPharmaceutical ScienceMedicineAgronomyDrug Discovery
2016English

In Vitro and in Vivo Assessment of Salmonella Enterica Serovar Typhimurium DT104 Virulence

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2001English

Correlating in Vitro Data to in Vivo Findings for Risk Assessment

Altex
MedicineMedical Laboratory TechnologyPharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy